Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $401.81B.
ENTERPRISE VALUE (EV)
$401.81B
Merck & Co., Inc.
Market Cap
$366.74B
Enterprise Value (EV)
$401.81B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Merck & Co., Inc. (MRK) | $366.74B | $401.81B |
| UnitedHealth Group Incorporated (UNH)vs › | $364.02B | $408.13B |
| Roche Holding AG (RHHBY)vs › | $344.67B | $377.61B |
| AbbVie Inc. (ABBV)vs › | $439.68B | $503.94B |
| AstraZeneca PLC (AZN)vs › | $248.20B | $275.52B |
| Thermo Fisher Scientific Inc. (TMO)vs › | $224.09B | $264.27B |
| Amgen Inc. (AMGN)vs › | $212.20B | $255.51B |
| Novo Nordisk A/S (NVO)vs › | $200.54B | $215.11B |
| Abbott Laboratories (ABT)vs › | $182.59B | $210.09B |
| Gilead Sciences, Inc. (GILD)vs › | $182.06B | $205.13B |
Market Cap
$366.74B
Total Debt
$49.63B
Cash
$14.56B
Enterprise Value
$401.81B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
